Liposomal delivery of anti-cancer drug combinations: formulation considerations & mechanisms of action
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: CHIU, Gigi (National University of Singapore, Dept of Pharmacy, Singapore, Singapore)
Background: Liposomes have been promising delivery systems, and have gained attention especially in the treatment of cancer. While the currently approved liposome formulations all contain only one anti-cancer drug, the use of drug cocktails is the norm in the clinical setting. Thus, further development of liposomal formulations has progressed to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.